{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:40:06Z","timestamp":1794944406353,"version":"4.9.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The coronavirus disease 2019 pandemic has resulted in a growing population of individuals who experience a wide range of persistent symptoms referred to as \u201clong COVID.\u201d Symptoms include neurocognitive impairment and fatigue. Two potential mechanisms could be responsible for these long-term unremitting symptoms: hypercoagulability, which increases the risk of blood vessel occlusion, and an uncontrolled continuous inflammatory response. Currently, no known treatment is available for long COVID. One of the options to reverse hypoxia, reduce neuroinflammation, and induce neuroplasticity is hyperbaric oxygen therapy. In this article, we present the first case report of a previously healthy athletic individual who suffered from long COVID syndrome treated successfully with hyperbaric oxygen therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A previously healthy 55-year-old Caucasian man presented 3\u00a0months after severe coronavirus disease 2019 infection with long COVID syndrome. His symptoms included a decline in memory, multitasking abilities, energy, breathing, and physical fitness. After evaluation that included brain perfusion magnetic resonance imaging, diffusion tensor imaging, computerized cognitive tests, and cardiopulmonary test, he was treated with hyperbaric oxygen therapy. Each session included exposure to 90\u00a0minutes of 100% oxygen at 2 atmosphere absolute pressure with 5-minute air breaks every 20\u00a0minutes for 60 sessions, 5\u00a0days per week. Evaluation after completing the treatment showed significant improvements in brain perfusion and microstructure by magnetic resonance imaging and significant improvement in memory with the most dominant effect being on nonverbal memory, executive functions, attention, information procession speed, cognitive flexibility, and multitasking. The improved cognitive functions correlated with the increased cerebral blood flow in brain regions as measured by perfusion magnetic resonance imaging. With regard to physical capacity, there was a 34% increase in the maximum rate of oxygen consumed during exercise and a 44% improvement in forced vital capacity. The improved physical measurements correlated with the regain of his pre-COVID physical capacity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We report the first case of successfully treated long COVID symptoms with hyperbaric oxygen therapy with improvements in cognition and cardiopulmonary function. The beneficial effects of hyperbaric oxygen shed additional light on the pathophysiology of long COVID. As this is a single case report, further prospective randomized control studies are needed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03287-w","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T17:01:27Z","timestamp":1644944487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Hyperbaric oxygen treatment for long coronavirus disease-19: a\u00a0case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Aisha M.","family":"Bhaiyat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Sasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemer","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Khairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouzayan","family":"Ginzarly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umair","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moin","family":"Fikree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Efrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"issue":"1","key":"3287_CR1","doi-asserted-by":"publisher","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","volume":"11","author":"S Lopez-Leon","year":"2021","unstructured":"Lopez-Leon S, et\u00a0al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.","journal-title":"Sci Rep"},{"issue":"6","key":"3287_CR2","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"M Levi","year":"2020","unstructured":"Levi M, et\u00a0al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438\u201340.","journal-title":"Lancet Haematol"},{"key":"3287_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155151","volume":"133","author":"M Mahmudpour","year":"2020","unstructured":"Mahmudpour M, et\u00a0al. COVID-19 cytokine storm: the anger of inflammation. Cytokine. 2020;133: 155151.","journal-title":"Cytokine"},{"key":"3287_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pneurobio.2017.10.006","volume":"159","author":"B Li","year":"2017","unstructured":"Li B, et\u00a0al. Brain\u2013immune interactions in perinatal hypoxic-ischemic brain injury. Prog Neurobiol. 2017;159:50\u201368.","journal-title":"Prog Neurobiol"},{"key":"3287_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neurobiolaging.2017.10.007","volume":"62","author":"R Shapira","year":"2018","unstructured":"Shapira R, et\u00a0al. Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation. Neurobiol Aging. 2018;62:105\u201319.","journal-title":"Neurobiol Aging"},{"issue":"10302","key":"3287_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(21)01755-4","volume":"398","author":"L Huang","year":"2021","unstructured":"Huang L, et\u00a0al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747\u201358.","journal-title":"Lancet"},{"key":"3287_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-015-1034-2","volume":"19","author":"A Hadanny","year":"2015","unstructured":"Hadanny A, Efrati S. Oxygen\u2014a limiting factor for brain recovery. Crit Care. 2015;19:307.","journal-title":"Crit Care"},{"issue":"10300","key":"3287_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","volume":"398","author":"I Katsoularis","year":"2021","unstructured":"Katsoularis I, et\u00a0al. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398(10300):599\u2013607.","journal-title":"Lancet"},{"key":"3287_CR9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3389\/fphys.2018.00995","volume":"9","author":"I Pena-Villalobos","year":"2018","unstructured":"Pena-Villalobos I, et\u00a0al. Hyperbaric oxygen increases stem cell proliferation, angiogenesis and wound-healing ability of WJ-MSCs in diabetic mice. Front Physiol. 2018;9:995.","journal-title":"Front Physiol"},{"issue":"1","key":"3287_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cardiores.2006.06.031","volume":"72","author":"BP Cabigas","year":"2006","unstructured":"Cabigas BP, et\u00a0al. Hyperoxic and hyperbaric-induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc Res. 2006;72(1):143\u201351.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3287_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s004210100503","volume":"86","author":"P Gregorevic","year":"2001","unstructured":"Gregorevic P, Lynch GS, Williams DA. Hyperbaric oxygen modulates antioxidant enzyme activity in rat skeletal muscles. Eur J Appl Physiol. 2001;86(1):24\u20137.","journal-title":"Eur J Appl Physiol"},{"issue":"4","key":"3287_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3171\/jns.2007.106.4.687","volume":"106","author":"Z Zhou","year":"2007","unstructured":"Zhou Z, et\u00a0al. Protection of mitochondrial function and improvement in cognitive recovery in rats treated with hyperbaric oxygen following lateral fluid-percussion injury. J Neurosurg. 2007;106(4):687\u201394.","journal-title":"J Neurosurg"},{"issue":"1","key":"3287_CR13","first-page":"93","volume":"38","author":"A Hadanny","year":"2020","unstructured":"Hadanny A, et\u00a0al. Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients\u2014a retrospective analysis. Restor Neurol Neurosci. 2020;38(1):93\u2013107.","journal-title":"Restor Neurol Neurosci"},{"issue":"2","key":"3287_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1152\/japplphysiol.00235.2013","volume":"116","author":"M Horie","year":"2014","unstructured":"Horie M, et\u00a0al. Enhancement of satellite cell differentiation and functional recovery in injured skeletal muscle by hyperbaric oxygen treatment. J Appl Physiol. 2014;116(2):149\u201355.","journal-title":"J Appl Physiol"},{"issue":"1","key":"3287_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12890-019-0893-8","volume":"19","author":"A Hadanny","year":"2019","unstructured":"Hadanny A, et\u00a0al. Hyperbaric oxygen therapy effects on pulmonary functions: a prospective cohort study. BMC Pulm Med. 2019;19(1):148.","journal-title":"BMC Pulm Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03287-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T17:01:48Z","timestamp":1644944508000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03287-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3287"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03287-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]},"assertion":[{"value":"11 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AMB, ZW, SK, MG, and UQ work for AVIV Clinics. ES works for AVIV Scientific LTD. SE is a co-founder and shareholder at AVIV Scientific LTD.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}